Status:
COMPLETED
A Study of Gaboxadol in Primary Insomnia
Lead Sponsor:
H. Lundbeck A/S
Conditions:
Primary Insomnia
Eligibility:
All Genders
66+ years
Phase:
PHASE3
Brief Summary
To evaluate the safety and tolerability of gaboxadol in primary insomnia.
Detailed Description
To obtain long-term safety data in elderly patients with gaboxadol.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients with a diagnosis of primary insomnia
Exclusion
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
November 1 2006
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT00209846
Start Date
June 1 2004
End Date
November 1 2006
Last Update
March 30 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Non-US study, principal location:
Gothenburg, Sweden